Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: King Pharmaceuticals Ltd, Donegal Street, Ballybofey, County Donegal, Ireland
CYCLOSERINE.
| Pharmaceutical Form |
|---|
|
Capsule, hard. |
Each capsule contains as active ingredient 250 mg of cycloserine.
| Active Ingredient | Description | |
|---|---|---|
| Cycloserine |
Cycloserine is an analog of the amino acid D-alanine. It interferes with an early step in bacterial cell wall synthesis in the cytoplasm by competitive inhibition of two enzymes, L-alanine racemase, which forms D-alanine from L-alanine, and D-alanylalanine synthetase, which incorporates D-alanine into the pentapeptide necessary for peptidoglycan formation and bacterial cell wall synthesis. |
| List of Excipients |
|---|
|
Talc |
Cycloserine capsules are red and grey.
HDPE bottles of 100 capsules fitted with a child resistant, HDPE/polypropylene cap with an induction heat sealed liner. 1 desiccant disc (HDPE canister containing 3g silica gel) is included in each bottle.
King Pharmaceuticals Ltd, Donegal Street, Ballybofey, County Donegal, Ireland
PL 14385/0005
Date of first authorisation: October 1996
Date of latest renewal: 31 May 2007
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
